Record Details

DFT and Molecular Docking Studies of an Antiviral Drug: Molnupiravir

NOPR - NISCAIR Online Periodicals Repository

View Archive Info
 
 
Field Value
 
Title DFT and Molecular Docking Studies of an Antiviral Drug: Molnupiravir
 
Creator Mishra, Abhinav
Sharma, Dipendra
Tiwari, Sugriva Nath
 
Subject Molnupiravir
COVID-19
Glucocorticoid receptor
DFT
 
Description 810-812
This paper presents computational analysis of molnupiravir, the first orally administered antiviral drug approved by
MHRA for the cure of COVID-19. Molnupiravir is the derivative of N4-hydroxycytidine with a ribose residue attached to an
isobutyrate ester group. Method based on DFT has been employed to establish the optimised structure, electronic and optical
parameters of the drug molecule. Further, molecular docking of molnupiravir on SARS-CoV-2 protein, glucocorticoid
receptor (PDB ID: 1M2Z) has been performed so as to examine the preferred affinity and binding pattern of the drug.
 
Date 2023-09-21T05:09:20Z
2023-09-21T05:09:20Z
2023-09
 
Type Article
 
Identifier 0975-0959 (Online); 0301-1208 (Print)
http://nopr.niscpr.res.in/handle/123456789/62549
https://doi.org/10.56042/ijpap.v61i9.3125
 
Language en
 
Publisher NIScPR-CSIR, India
 
Source IJPAP Vol.61(09) [September 2023]